Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Dec 2025 is -33.90% vs 59.44% in Dec 2024
Consolidate Net Profit
YoY Growth in quarter ended Dec 2025 is -35.80% vs 124.18% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Dec 2025 is -26.65% vs 290.64% in Dec 2024
Interest
YoY Growth in quarter ended Dec 2025 is 44.28% vs 58.48% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Dec 2025 has fallen from Dec 2024
Compare Quarterly Results Of Shin Nippon Biomedical Laboratories, Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Dec 2025 is -22.44% vs 27.96% in Sep 2025
YoY Growth in quarter ended Dec 2025 is -33.90% vs 59.44% in Dec 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Dec 2025 is 53.13% vs 204.60% in Sep 2025
YoY Growth in quarter ended Dec 2025 is -35.80% vs 124.18% in Dec 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Dec 2025 is 54.07% vs 198.86% in Sep 2025
YoY Growth in quarter ended Dec 2025 is -26.65% vs 290.64% in Dec 2024
Quarterly - Interest
QoQ Growth in quarter ended Dec 2025 is 13.99% vs 18.69% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 44.28% vs 58.48% in Dec 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025
YoY Growth in quarter ended Dec 2025 has fallen from Dec 2024






